Medlab Clinical (Medlab Clinical) Pre-Tax Income : $-2.39 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Medlab Clinical Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Medlab Clinical's pretax income for the six months ended in Dec. 2023 was $-1.33 Mil. Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.39 Mil. Medlab Clinical's pretax margin was -4,143.75%.

During the past 8 years, Medlab Clinical's highest Pretax Margin was -114.96%. The lowest was -1040.94%. And the median was -249.08%.

Medlab Clinical Pre-Tax Income Historical Data

The historical data trend for Medlab Clinical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medlab Clinical Pre-Tax Income Chart

Medlab Clinical Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Pre-Tax Income

Get a 7-Day Free Trial

-5.68

-9.31

-9.48

-5.90

-4.32

Medlab Clinical Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial												-3.04	-2.91	-3.28	-1.06	-1.33

Competitive Comparison of Medlab Clinical's Pre-Tax Income

For the Biotechnology subindustry, Medlab Clinical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medlab Clinical's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medlab Clinical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Medlab Clinical's Pre-Tax Income falls into.

Medlab Clinical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Medlab Clinical's Pretax Income for the fiscal year that ended in Jun. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-6.633	+	2.303	+	-0.001	+	0.035	+	-0.021
	=	-4.32

Medlab Clinical's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pretax Income	=	Operating Income	+	Non Operating Income	+	Interest Expense	+	Interest Income	+	Other
	=	-1.337	+	0.01	+	-0.001	+	0.002	+	-2.2204460492503E-16
	=	-1.33

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.39 Mil.

Medlab Clinical (OTCPK:MDBBF) Pre-Tax Income Explanation

Medlab Clinical's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pretax Income	/	Revenue
	=	-1.326	/	0.032
	=	-4,143.75%

During the past 8 years, Medlab Clinical's highest Pretax Margin was -114.96%. The lowest was -1040.94%. And the median was -249.08%.

Medlab Clinical Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Medlab Clinical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Medlab Clinical (Medlab Clinical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medlab Clinical Ltd (OTCPK:MDBBF) » Definitions » Pre-Tax Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

11 Lord Street, Unit 5, Botany, NSW, AUS, 2019

Website

https://www.medlab.co

Medlab Clinical Ltd is a medical research and development company. It is engaged in researching and formulating novel biotherapeutics to improve health outcomes in early to moderate stage chronic diseases such as chronic kidney disease, pre-diabetes, and obesity. Some of the company's nutraceutical products are Multibiotic, Mg Optima Relax, NRGBiotic, NanoCelle D3, SB 5B and others. The principal segments of the group are Nutraceutical which includes the sale of nutraceutical products; and Pharmaceutical research. It generates the majority of the revenue from the sale of nutraceutical products. The business operations of the firm are carried out from Australia.